Evidence map›Paper›PMID 33979589›Full record

ArticleImmunity2021

Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses.

Ke Xu, Na Yin, Min Peng, Efstathios G Stamatiades, Sagar Chhangawala, Amy Shyu, Peng Li, Xian Zhang, Mytrang H Do, Kristelle J Capistrano and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Contextualizing TNature reviews. Immunology · 2026
    Review
  6. NIBAN2/FLII/RREB1 Axis Drives Glioma Stem Cell Malignancy via TLR3 Pathway Activation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. ALDH1L1 reverses CD8Journal of translational medicine · 2026
    Article
  11. Review
  12. Metabolic control of innate-like T cells.Nature reviews. Immunology · 2026
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Ke XuImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology and Microbial Pathogenesis Graduate Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
Na YinImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Min PengImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Efstathios G StamatiadesImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sagar ChhangawalaComputational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Physiology Biophysics and Systems Biology Graduate Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
Amy ShyuImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Peng LiImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Xian ZhangImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Mytrang H DoImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology and Microbial Pathogenesis Graduate Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
Kristelle J CapistranoImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Chun ChouImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Christina S LeslieComputational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Physiology Biophysics and Systems Biology Graduate Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
Ming O LiImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology and Microbial Pathogenesis Graduate Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: lim@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Nutrient Sensing and mTORC1 Signaling in the Control of Regulatory T Cell Generation and FunctionR01AI102888 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI LI, MING · 2014 to 2022
$4.3M
NCI NIH HHS P30 CA008748NIAID NIH HHS R01 AI102888
6 · The paper itself

Abstract

Aerobic glycolysis-the Warburg effect-converts glucose to lactate via the enzyme lactate dehydrogenase A (LDHA) and is a metabolic feature of effector T cells. Cells generate ATP through various mechanisms and Warburg metabolism is comparatively an energy-inefficient glucose catabolism pathway. Here, we examined the effect of ATP generated via aerobic glycolysis in antigen-driven T cell responses. Cd4

Indexed as

Adenosine TriphosphateAnimalsCell DifferentiationCell LineCell ProliferationFemaleGene Expression Regulation, NeoplasticGlucoseGlycogen Storage DiseaseGlycolysisL-Lactate DehydrogenaseMaleMiceMice, Inbred C57BLMice, TransgenicPhosphatidylinositol 3-KinaseAdenosine TriphosphateGlucoseL-Lactate DehydrogenasePhosphatidylinositol 3-KinaseATPautoimmunityglycolysisLDHAPI3Kredox balanceTh17 cell

Identifiers

PMID33979589
PMCPMC8130647
OpenAlexW3162194020

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.